Literature DB >> 30017564

Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association.

Altaira D Dearborn1, Elif Eren2, Norman R Watts1, Ira W Palmer1, Joshua D Kaufman1, Alasdair C Steven2, Paul T Wingfield3.   

Abstract

HIV-1 Rev protein mediates nuclear export of unspliced and partially spliced viral RNAs for production of viral genomes and structural proteins. Rev assembles on a 351-nt Rev response element (RRE) within viral transcripts and recruits host export machinery. Small (<40-nt) RNA aptamers that compete with the RRE for Rev binding inhibit HIV-1 viral replication. We determined the X-ray crystal structure of a potential anti-HIV-1 aptamer that binds Rev with high affinity (Kd = 5.9 nM). The aptamer is structurally similar to the RRE high-affinity site but forms additional contacts with Rev unique to its sequence. Exposed bases of the aptamer interleave with the guanidinium groups of two arginines of Rev, forming stacking interactions and hydrogen bonds. The aptamer also obstructs an oligomerization interface of Rev, blocking Rev self-assembly. We propose that this aptamer can inhibit HIV-1 replication by interfering with Rev-RRE, Rev-Rev, and possibly Rev-host protein interactions. Published by Elsevier Ltd.

Entities:  

Keywords:  HIV-1; Rev; aptamer; assembly; inhibitor

Mesh:

Substances:

Year:  2018        PMID: 30017564      PMCID: PMC7319042          DOI: 10.1016/j.str.2018.06.001

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  40 in total

1.  Implications of the HIV-1 Rev dimer structure at 3.2 A resolution for multimeric binding to the Rev response element.

Authors:  Michael A DiMattia; Norman R Watts; Stephen J Stahl; Christoph Rader; Paul T Wingfield; David I Stuart; Alasdair C Steven; Jonathan M Grimes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

2.  HIV-1 Rev expressed in recombinant Escherichia coli: purification, polymerization, and conformational properties.

Authors:  P T Wingfield; S J Stahl; M A Payton; S Venkatesan; M Misra; A C Steven
Journal:  Biochemistry       Date:  1991-07-30       Impact factor: 3.162

3.  Expression of small, therapeutic RNAs in human cell nuclei.

Authors:  P D Good; A J Krikos; S X Li; E Bertrand; N S Lee; L Giver; A Ellington; J A Zaia; J J Rossi; D R Engelke
Journal:  Gene Ther       Date:  1997-01       Impact factor: 5.250

4.  Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev.

Authors:  Stephen J Stahl; Norman R Watts; Christoph Rader; Michael A DiMattia; Rose G Mage; Ira Palmer; Joshua D Kaufman; Jonathan M Grimes; David I Stuart; Alasdair C Steven; Paul T Wingfield
Journal:  J Mol Biol       Date:  2010-02-04       Impact factor: 5.469

5.  Solution oligomerization of the rev protein of HIV-1: implications for function.

Authors:  J L Cole; J D Gehman; J A Shafer; L C Kuo
Journal:  Biochemistry       Date:  1993-11-09       Impact factor: 3.162

6.  The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export.

Authors:  M Neville; F Stutz; L Lee; L I Davis; M Rosbash
Journal:  Curr Biol       Date:  1997-10-01       Impact factor: 10.834

7.  A new HIV-1 Rev structure optimizes interaction with target RNA (RRE) for nuclear export.

Authors:  Norman R Watts; Elif Eren; Xiaolei Zhuang; Yun-Xing Wang; Alasdair C Steven; Paul T Wingfield
Journal:  J Struct Biol       Date:  2018-03-29       Impact factor: 2.867

8.  How good are my data and what is the resolution?

Authors:  Philip R Evans; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-06-13

9.  Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.

Authors: 
Journal:  Lancet HIV       Date:  2017-05-10       Impact factor: 12.767

10.  RNA-directed remodeling of the HIV-1 protein Rev orchestrates assembly of the Rev-Rev response element complex.

Authors:  Bhargavi Jayaraman; David C Crosby; Christina Homer; Isabel Ribeiro; David Mavor; Alan D Frankel
Journal:  Elife       Date:  2014-12-08       Impact factor: 8.140

View more
  5 in total

1.  HIV Rev-isited.

Authors:  Catherine Toni-Sue Truman; Aino Järvelin; Ilan Davis; Alfredo Castello
Journal:  Open Biol       Date:  2020-12-23       Impact factor: 6.411

2.  Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer.

Authors:  Jakub Ptacek; Dong Zhang; Liming Qiu; Sven Kruspe; Lucia Motlova; Petr Kolenko; Zora Novakova; Shambhavi Shubham; Barbora Havlinova; Petra Baranova; Shi-Jie Chen; Xiaoqin Zou; Paloma Giangrande; Cyril Barinka
Journal:  Nucleic Acids Res       Date:  2020-11-04       Impact factor: 16.971

Review 3.  Aptamers for Anti-Viral Therapeutics and Diagnostics.

Authors:  Tae-Hyeong Kim; Seong-Wook Lee
Journal:  Int J Mol Sci       Date:  2021-04-17       Impact factor: 5.923

Review 4.  Aptamers-Diagnostic and Therapeutic Solution in SARS-CoV-2.

Authors:  Tomasz Wandtke; Ewelina Wędrowska; Marcin Szczur; Grzegorz Przybylski; Marek Libura; Piotr Kopiński
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

5.  Binding stoichiometry and structural model of the HIV-1 Rev/importin β complex.

Authors:  Didier Spittler; Rose-Laure Indorato; Elisabetta Boeri Erba; Elise Delaforge; Luca Signor; Simon J Harris; Isabel Garcia-Saez; Andrés Palencia; Frank Gabel; Martin Blackledge; Marjolaine Noirclerc-Savoye; Carlo Petosa
Journal:  Life Sci Alliance       Date:  2022-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.